E Fund Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$119K Sell
10,765
-4,128
-28% -$25.3K ﹤0.01% 470
2026
Q1
$114K Buy
+14,893
New +$114K ﹤0.01% 470
2024
Q2
Sell
-30,342
Closed -$248K 366
2024
Q1
$248K Buy
30,342
+5,603
+23% +$46K 0.02% 301
2023
Q4
$209K Buy
+24,739
New +$287K 0.01% 276
2023
Q2
Sell
-12,305
Closed -$217K 332
2023
Q1
$217K Buy
+12,305
New +$293K 0.02% 284

Other funds holding REPL

E Fund Management's REPL Position: Q2 2026 in Review

E Fund Management reduced its Replimune Group (REPL) stake by 28% in Q2 2026, selling an estimated $25.3K and leaving 10,765 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

E Fund Management first reported a position in REPL in Q1 2023 and has held it in 5 quarters since. The position peaked at $248K in Q1 2024. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • E Fund Management held 10,765 shares of Replimune Group worth $119K as of Q2 2026.
  • E Fund Management sold 4,128 Replimune Group shares in Q2 2026, an estimated $25.3K.
  • Replimune Group made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #470 holding.
  • E Fund Management first reported a position in Replimune Group in Q1 2023 and has held it in 5 quarters since.
  • E Fund Management's Replimune Group position peaked at $248K in Q1 2024.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.